The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
In 2001, The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute was founded as a…
In 2000, researchers from Lawrence Berkeley, Lawrence Livermore, and Los Alamos national laboratories at the Joint Genome Institute…
In 1997, a mouse model of promyelocytic leukemia was developed by Washington University – St. Louis researcher Timothy…
In 1997, the National Cancer Institute (NCI) and Chinese scientists found that occupational exposure to benzene is associated…
In 1997, cancer stem cells were first identified in acute myelogenous leukemia. They will later be identified in…
In 1995, The U.S. Food and Drug Administration (FDA) approved tretinoin, a differentiating agent related to vitamin A,…
In 1994, Washington University – St. Louis reseacher Lee Ratern, MD and colleagues announced they had developed an…
In 1992, the Oregon Cancer Center, later known as the OHSU Cancer Institute, was founded at Oregon Health…
In 1988, Gertrude B. Elion shared the Nobel Prize in Physiology or Medicine for the ‘discoveries of important…
In 1987, The Cold Spring Harbor Laboratory (CSHL) Cancer Center received National Cancer Institute (NCI) designation. CSHL researchers…
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…
In 1980, National Cancer Institute (NCI) scientists isolated human T-cell lymphotrophic virus 1 (HTLV-1). This virus, which is…
In 1976, interleukin-2 was discovered and purified which allowed researchers to grow T-cells and study their immunology, which…
In 1975, Dr. E. Donnall Thomas, a pioneer in bone marrow transplantation, secured a permanent treatment home at…
In 1968, the world’s first successful bone-marrow transplant was completed at the University of Minnesota Hospital under the…
In 1967, E.R. Squibb & Sons delved into cancer research, discovering and developing hydroxyurea for leukemia and advanced…
In 1966, a group of St. Jude patients were the first acute lymphoblastic leukemia (ALL) patients to ever…
In 1966, a group of St. Jude patients were the first acute lymphoblastic leukemia (ALL) patients to ever…
On May 7, 1962, the Acute Leukemia Task Force held its first meeting. It focused the combined efforts…
In 1962, the U.S. Centers for Disease Control and Prevention (CDC) performed the first Epidemic Intelligence Service (EIS)…
In 1960, chromosome abnormalities were associated with leukemias.
In 1958, NCI scientists pioneer the use of combination chemotherapy. Partial and complete remissions, as well as prolonged…
On Dec. 7, 1953, the U.S. Food and Drug Administration (FDA) approved methotrexate, an antimetabolite derived from folic…
On Feb. 8, 1951, Henrietta Lacks, a tobacco farmer from Virginia died from cervical cancer, and a scientist…
From 1951 to 1976, the Oklahoma Medical Research Foundation (OMRF) treated some of the state’s sickest children, most…
In 1949, The Leukemia & Lymphoma Society (LLS) was founded in New York. The LLS mission is to…
In 1948, George Hitchings and Hitchings and laboratory assistant Gertrude Elion synthesized 6-mercaptopurine (6-MP), an antimetabolite, to combat…
In 1947, biochemist Yellapragada SubbaRow co-discovered the first cancer chemotherapy agent for children suffering from acute leukemia. He…
In 1947, Sidney Farber finds that a folic acid derivative inhibits acute leukemia. This first antimetabolite leads to…